Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Hemangioma, Capillary 2Motor Activity 1Lymphoma 1Liver Cirrhosis 1Leukemia 1Hemangioma 1Carcinoma, Hepatocellular 1

Interventions

Timolol 7Propranolol 7Lasers, Dye 3Population Groups 2Nadolol 2Imiquimod 2Atenolol 2ziprasidone 1propranolol mustard 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Ultrasonography 1Tranexamic Acid 1Tobramycin 1Surgery, Computer-Assisted 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Ophthalmic Solutions 1Ointments 1Nifedipine 1Nafcillin 1Mupirocin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hemangioma, Capillary × Nadolol × Clear all
NCT01010308 2021-08-19

Nadolol for Proliferating Infantile Hemangiomas

The Hospital for Sick Children

Phase 2 Completed
20 enrolled

Hemangioma, Capillary

NCT02505971 2020-10-28

Nadolol Versus Propranolol in Children With Infantile Hemangiomas

The Hospital for Sick Children

Phase 3 Completed
74 enrolled

Hemangioma, Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡